Antiretroviral Resistance After First-Line Antiretroviral Therapy Failure in Diverse HIV-1 Subtypes in the SECOND-LINE Study-Reference-Cited by-同舟云学术

Antiretroviral Resistance After First-Line Antiretroviral Therapy Failure in Diverse HIV-1 Subtypes in the SECOND-LINE Study

Published:2016-09 Issue:9 Volume:32 Page:841-850
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

Lam Edward P.¹,Moore Cecilia L.¹,Gotuzzo Eduardo²,Nwizu Chidi³,Kamarulzaman Adeeba⁴,Chetchotisakd Ploenchan⁵,van Wyk Jean⁶,Teppler Hedy⁷,Kumarasamy Nagalingeswaran⁸,Molina Jean-Michel⁹,Emery Sean¹,Cooper David A.¹,Boyd Mark A.¹¹⁰,

Affiliation:

1. The Kirby Institute UNSW Australia, Sydney, Australia.

2. Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano, Heredia, Lima, Peru.

3. Center for Clinical Care and Clinical Research in Nigeria, Abuja, Nigeria.

4. Clinical Investigations Centre, University of Malaya, Kuala Lumpur, Malaysia.

5. Infectious Diseases Unit, Srinagarind Hospital, Khon Kaen University, Thailand.

6. AbbVie, North Chicago, Illinois.

7. Merck & Co., Inc., Kenilworth, New Jersey.

8. YRG Care, Chennai, India.

9. Department of Clinical Infectious Diseases, Hôpital Saint-Louis, Paris, France.

10. University of Adelaide, Lyell McEwin Hospital, Adelaide, South Australia, Australia.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/aid.2015.0331

Reference40 articles.

1. The 2013 WHO guidelines for antiretroviral therapy

2. Drug Susceptibility and Resistance Mutations After First-Line Failure in Resource Limited Settings

3. Virological follow-up of adult patients in antiretroviral treatment programmes in sub-Saharan Africa: a systematic review

4. Low Levels of Antiretroviral‐Resistant HIV Infection in a Routine Clinic in Cameroon that Uses the World Health Organization (WHO) Public Health Approach to Monitor Antiretroviral Treatment and Adequacy with the WHO Recommendation for Second‐Line Treatment

5. High prevalence of HIV-1 drug resistance among patients on first-line antiretroviral treatment in Lomé, Togo

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of Dolutegravir versus Darunavir in Antiretroviral First-Line Regimens According to Resistance Mutations and Viral Subtype;Viruses;2023-03-16

2. We should not stop considering HIV drug resistance testing at failure of first-line antiretroviral therapy;The Lancet HIV;2023-03

3. Resistance profile of HIV-1 quasispecies in patients under treatment failure using single molecule, real-time sequencing;AIDS;2020-09-28

4. Effectiveness of boosted darunavir plus rilpivirine in patients with long-lasting HIV-1 infection: DARIL study;Journal of Antimicrobial Chemotherapy;2020-03-05

5. Human Immunodeficiency Virus-1 Viral Load Is Elevated in Individuals With Reverse-Transcriptase Mutation M184V/I During Virological Failure of First-Line Antiretroviral Therapy and Is Associated With Compensatory Mutation L74I;The Journal of Infectious Diseases;2019-11-27